JENNIFER THOMAS: Open Payments
NPI 1104488386 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 27 payments from 14 companies in 2025. Trend: 2023 $507 · 2024 $494 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| Actelion Pharmaceuticals US, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Novo Nordisk Inc | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Edwards Lifesciences Corporation | 1 | $25 |
| Dexcom, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $19 |
Products named: LEQVIO, VERQUVO, CAMZYOS, Kerendia, OPSUMIT, EDARBI, OPSYNVI, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV).
Industry payments across TX — which companies pay providers there.
